Glioblastoma with BRAFV600E mutation and numerous metastatic foci: a case report

by Karolina Janik, Waldemar Och, Marta Popeda, Kamila Rosiak, Joanna Peciak, Piotr Rieske, Kamil Kulbacki, Blazej Szostak, Agnieszka Parda, Ewelina Stoczynska-Fidelus
Published 2019-03-01

Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor

by Jinwoong Kim, Byeongha Choi, Daseul Im, Hoyong Jung, Hyungwoo Moon, Waqar Aman, Jung-Mi Hah
Published 2019-01-01

Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules

by Tatiana Marina Vieira Giorgenon, Fabiane Tavares Carrijo, Maurício Alamos Arruda, Taíse Lima Oliveira Cerqueira, Haiara Ramos Barreto, Juliana Brandão Cabral, Thiago Magalhães da Silva, Patrícia Künzle Ribeiro Magalhães, Léa Maria Zanini Maciel, Helton Estrela Ramos
Published 2019-03-01

Vemurafenib resistant melanoma cells acquire mesenchymal stem cell-like properties

by A. A. Vartanian, O. S. Burova, Kh. S. Vishnyakova, I. V. Samoylenko, V. A. Misyurin, E. E. Egorov, O. O. Ryabaya, M. A. Baryshnikova
Published 2019-12-01

Association between BRAFV600E mutation and the clinicopathological features in incidental papillary thyroid microcarcinoma: A single-center study in Turkish patients

by Havva Sezer, Nihal Üren, Dilek Yazıcı
Published 2020-08-01

DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of papillary thyroid cancer

by Ma B, Shi RL, Yang SW, Zhou L, Qu N, Liao T, Wang Y, Wang YL, Ji QH
Published 2016-04-01

Profile and clinical implication of circular RNAs in human papillary thyroid carcinoma

by Huihui Ren, Zhelong Liu, Siyue Liu, Xinrong Zhou, Hong Wang, Jinchao Xu, Daowen Wang, Gang Yuan
Published 2018-08-01

Case Report: Anlotinib Therapy in a Patient With Recurrent and Metastatic RAIR-DTC Harboring Coexistent TERT Promoter and BRAFV600E Mutations

by Yanjun Su, Shaohao Cheng, Jun Qian, Min Zhang, Tuanli Li, Ying Zhang, Chang Diao, Ling Zhang, Ruochuan Cheng
Published 2021-03-01

Efeitos citotóxicos do DM-1 em células de melanoma resistentes a um inibidor de BRAF e na expressão de metaloproteinases

by Nayane de Souza
Published 2017

Efeitos citotóxicos do DM-1 em células de melanoma resistentes a um inibidor de BRAF e na expressão de metaloproteinases

by Souza, Nayane de
Published 2017

Bases moléculaires de l’histiocytose langerhansienne

by Héritier, Sébastien
Published 2017

Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases

by Romain Appay, Mélanie Pages, Carole Colin, David T. W. Jones, Pascale Varlet, Dominique Figarella-Branger
Published 2020-06-01

Correlation of the BRAFV600E and RAS mutations with clinicopathological characteristics of papillary thyroid cancer using TCGA database analysis

by Yue Zhao, Bing-Jie Wu, Duo-Duo Wang
Published 2019-01-01

Rethinking the role of oncogenes in papillary thyroid cancer initiation

by Mario eVitale
Published 2012-06-01

Complete response with fluorouracil and irinotecan with a BRAFV600E and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report

by Wang Z, Dai WP, Zang YS
Published 2019-01-01

Multifocal BRAFV600E-Mutated Melanoma in situ on the Foot

by Eimei Iwama, Taku Fujimura, Yoshiyuki Kusakari, Takahiro Haga, Setsuya Aiba
Published 2015-10-01

Melanoma-Derived BRAFV600E Mutation in Peritumoral Stromal Cells: Implications for in Vivo Cell Fusion

by Zsuzsanna Kurgyis, Lajos V. Kemény, Tünde Buknicz, Gergely Groma, Judit Oláh, Ádám Jakab, Hilda Polyánka, Kurt Zänker, Thomas Dittmar, Lajos Kemény, István B. Németh
Published 2016-06-01

Meta-Analyses of Association Between BRAFV600E Mutation and Clinicopathological Features of Papillary Thyroid Carcinoma

by Qing Zhang, Shao-zheng Liu, Qing Zhang, Yan-xing Guan, Qing-jie Chen, Qin-yao Zhu
Published 2016-02-01

Diagnostic efficacy of brafv600e immunocytochemistry in thyroid aspirates in bethesda category iv and papillary thyroid carcinoma

by Nidhi Anand, Tushar Agrawal, Anurag Gupta, Saumya Shukla, Roma Pradhan, Nuzhat Husain
Published 2021-01-01

Identification of KIT as a Suppressor of BRAFV600E-Mutant Melanoma

by Neiswender, James V.
Published 2017